Hjem › Leukæmi › Georgia › Atlanta
Leukæmi kliniske forsøg i Atlanta, GA
11 studier for Leukæmi søger deltagere på steder i og omkring Atlanta (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
RekruttererObservationsstudie
- Children's Healthcare of Atlanta - Arthur M. Blank Hospital, Atlanta
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
RekruttererFase 1/2
- Emory Winship Cancer Institute, Atlanta
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
RekruttererFase 2
- Winship Cancer Institute - Emory University, Atlanta
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
RekruttererFase 1
- Emory Healthcare - The Emory Clinic, Atlanta
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
RekruttererFase 2
- Children's Healthcare of Atlanta at Egleston, Atlanta
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
RekruttererFase 1/2
- Research Site, Atlanta
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
RekruttererObservationsstudie
- Children's Healthcare of Atlanta - Egleston, Atlanta
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
RekruttererFase 2/3
- University of Emory - Winship Cancer Institute, Atlanta
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
RekruttererFase 1
- Emory Healthcare - The Emory Clinic, Atlanta
Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia
RekruttererFase 1
- Blood and Marrow Transplant Group of Georgia, Atlanta
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservationsstudie
- Massive Bio SYNERGY-AI site, Atlanta
Leukæmi forsøg i andre byer
- Houston, TX28 studier
- Boston, MA25 studier
- New York City, NY19 studier
- Los Angeles, CA16 studier
- Chicago, IL16 studier
- Durham, NC13 studier
- Baldwin Park, CA12 studier
- Columbus, OH12 studier
- Nashville, TN12 studier
- Philadelphia, PA12 studier
- Milwaukee, WI11 studier
- Seattle, WA11 studier
Andre studier i Atlanta
- Kræft (alle typer)49 studier
- Ikke-småcellet lungecancer47 studier
- Brystkræft41 studier
- Multipelt myelom41 studier
- Prostatakræft33 studier
- Akut myeloid leukæmi30 studier
- Ægstockræft29 studier
- Lungecancer29 studier
- Colorektal kræft29 studier
- Metastatisk cancer28 studier
- Hjertesvigt25 studier
- Alvorlig depressiv lidelse25 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.